JPH107581A - Arginase activity promoter - Google Patents
Arginase activity promoterInfo
- Publication number
- JPH107581A JPH107581A JP8155274A JP15527496A JPH107581A JP H107581 A JPH107581 A JP H107581A JP 8155274 A JP8155274 A JP 8155274A JP 15527496 A JP15527496 A JP 15527496A JP H107581 A JPH107581 A JP H107581A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- arginase activity
- extract
- arginase
- urea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、木通の抽出エキス
を有効成分として含有するアルギナーゼ活性促進剤に、
特に、皮膚中で水分を保持する保湿物質を皮膚細胞に産
生させて皮膚に潤いと艶を与える効果に優れた皮膚外用
剤の形態にあるもの、に関する。TECHNICAL FIELD [0001] The present invention relates to an arginase activity promoter containing an extract of Kindori as an active ingredient,
In particular, the present invention relates to a skin external preparation excellent in the effect of producing moisturizing substances that retain moisture in the skin by skin cells to give the skin moisture and gloss.
【0002】[0002]
【従来の技術】アルギナーゼは、アルギニンをオルニチ
ンと尿素に加水分解する尿素サイクル中の酵素であり、
脊椎動物の肝臓、腎臓などをはじめ生物界に広く分布し
ている。ヒト皮膚においても、その存在は古くから知ら
れており、アルギナーゼは、表皮細胞の増殖に関連した
ポリアミン生合成やプロリン生合成のためのオルニチン
の供給酵素として知られている。しかしながら、この酵
素の皮膚中での生理機能を保湿因子の産生に関連づけた
報告は見あたらず、さらに皮膚中のアルギナーゼ活性を
調節し皮膚に保湿効果を与えることを目的とする薬剤も
知られていない。また、化粧料などの皮膚外用剤の大き
な目的の一つに肌荒れ防止・改善があるけれども、従
来、この目的達成のために、各種保湿物質の配合が行わ
れてきた。しかしながら、これらの保湿剤を用いた手法
は、皮膚表面におけるその物質の物理化学的な保湿の性
質を利用しているだけであり、その物質の皮膚細胞にお
よぼす生理的な機能に基づくものではない。また、この
ような保湿物質は皮膚から除去されるとその効果が消失
するため、その効果は一過性であると言わざるを得な
い。従って、皮膚細胞に働きかけ保湿物質の産生を促す
薬剤の開発が望まれていた。一方、木通(モクツウ)は
アケビまたはその他同属植物の蔓性の茎を採取し輪切り
にして乾燥させたものであり、古来より漢方薬の成分と
して用いられてきた生薬である。木通の作用としては、
ストレス胃潰瘍発生予防効果があること{薬第95巻1179
頁(1975年)}、利尿作用があること{Chem. Phar. Bu
ll. 第27巻1464頁(1979年)}、抗炎症作用を有するこ
と{日本薬学会第90年会発表(1970年)}が知られてい
る。しかし、木通が、アルギナーゼ活性を高めること、
またこれにより木通を含む皮膚外用剤が皮膚中の尿素産
生を増大させて皮膚保湿能力を高める作用をもつことは
全く知られていない。BACKGROUND OF THE INVENTION Arginase is an enzyme in the urea cycle that hydrolyzes arginine into ornithine and urea.
It is widely distributed in the biological world, including vertebrate liver and kidney. Its existence has been known in human skin for a long time, and arginase is known as an ornithine supplying enzyme for polyamine biosynthesis and proline biosynthesis related to the proliferation of epidermal cells. However, no report has been found that relates the physiological function of this enzyme in the skin to the production of moisturizing factors, and there is no known drug that regulates arginase activity in the skin to give a moisturizing effect to the skin. . One of the major purposes of skin external preparations such as cosmetics is to prevent and improve skin roughness, but conventionally, various moisturizing substances have been blended to achieve this purpose. However, these moisturizers only rely on the physicochemical moisturizing properties of the substance on the skin surface, not on the physiological function of the substance on skin cells. . In addition, since such moisturizing substances lose their effects when removed from the skin, their effects must be said to be transient. Therefore, there has been a demand for the development of a drug that acts on skin cells to promote the production of moisturizing substances. On the other hand, Mokutsu (Mokutsu) is a crude drug that has been used as a component of Chinese herbal medicine since ancient times, which is obtained by collecting vine stems of akebi or other congener plants, cutting them into rings, and drying them. As a function of Kodori,
Effective in preventing stress stomach ulcers.
Page (1975)} Diuretic effect {Chem. Phar. Bu
ll., vol. 27, p. 1644 (1979), which has an anti-inflammatory effect, announced at the 90th Annual Meeting of the Pharmaceutical Society of Japan (1970). However, Kindori increases arginase activity,
Further, it has not been known at all that a skin external preparation containing Kinatsu has an effect of increasing urea production in the skin and enhancing skin moisturizing ability.
【0003】[0003]
【発明が解決しようとする課題】従って、本発明の目的
は、木通の抽出エキスを有効成分として含有するアルギ
ナーゼ活性促進剤、及び皮膚細胞のアルギナーゼ活性を
促進させることにより皮膚が本来持つ保湿物質を増大さ
せて皮膚に潤いと艶を与える効果に優れた皮膚外用剤の
形態にあるものを提供することである。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide an arginase activity promoter containing an extract of Kinatsu as an active ingredient, and a moisturizing substance originally possessed by skin by promoting arginase activity of skin cells. In the form of an external preparation for skin having an excellent effect of moisturizing and lubricating the skin by increasing the skin.
【0004】[0004]
【課題を解決するための手段】本発明者らは、このよう
な事情に鑑み、皮膚が本来持つ保湿性を向上させるべく
皮膚中の保湿成分の産生機序について鋭意研究を重ねて
きた。その結果、表皮におけるアルギナーゼの機能は、
細胞の増殖に関するものが主ではなく、皮膚細胞の分化
過程において発現する保湿因子としての尿素の産生が主
であることを見いだした。そこで本発明者らはこの発見
に基づき、表皮細胞内に存在するアルギナーゼを誘導
し、これにより皮膚保湿因子としての尿素の産生量を増
やす薬物の探索を続けた結果、木通抽出エキスが皮膚細
胞中のアルギナーゼを誘導することを見いだし、またそ
れを皮膚外用剤に配合することにより、上記目的を達成
することができるアルギナーゼ活性促進剤を得ることに
成功し、本発明を完成するに至った。すなわち、本発明
は、木通の抽出エキスを有効成分として含有するアルギ
ナーゼ活性促進剤、及び皮膚外用剤の形態にあるものを
提供する。Means for Solving the Problems In view of such circumstances, the present inventors have intensively studied the mechanism of producing moisturizing components in skin in order to improve the inherent moisturizing properties of skin. As a result, the function of arginase in the epidermis is
It was found that urea, which is a moisturizing factor expressed during the differentiation process of skin cells, was mainly involved in cell proliferation, not mainly cell proliferation. Based on this finding, the present inventors continued to search for a drug that induces arginase present in epidermal cells, thereby increasing the production of urea as a skin moisturizing factor. The present inventors have found that arginase is induced in the dermatitis, and by adding it to an external preparation for skin, they have succeeded in obtaining an arginase activity promoter which can achieve the above object, and have completed the present invention. That is, the present invention provides an arginase activity enhancer containing an extract of Kinatsu as an active ingredient, and a skin external preparation.
【0005】[0005]
【発明の実施の形態】本発明に係る木通の抽出エキスと
は、木通を、炭化水素、エステル類、ケトン類、エーテ
ル類、ハロゲン化炭化水素類、アルコール類、及び水の
いずれか1種又は2種以上と共に加熱還流あるいは浸漬
し、濾過して得られるものをいう。好ましくは、本発明
に係る木通の抽出エキスとは、乾燥後粉砕した30gの
木通に300mlの水を加え、70℃に加熱し、そして還
流しながら3時間、温浸した水抽出物をいう。この際得
られる抽出エキスを濃縮して乾燥固形物として用いても
よく、また上記効果を有する成分をさらに分離精製した
画分を用いてもよい。BEST MODE FOR CARRYING OUT THE INVENTION The extract of wood mush according to the present invention refers to a wood mock extracted from one of hydrocarbons, esters, ketones, ethers, halogenated hydrocarbons, alcohols and water. It refers to one obtained by heating or refluxing or dipping together with a seed or two or more kinds and filtering. Preferably, the extract of Kinatsu according to the present invention is obtained by adding 300 ml of water to 30 g of dry and pulverized Kinatsu, heating to 70 ° C. and refluxing for 3 hours while refluxing. Say. At this time, the obtained extract may be concentrated and used as a dry solid, or a fraction obtained by further separating and purifying the component having the above effect may be used.
【0006】本発明における木通抽出エキスの配合量
は、乾燥固形物として皮膚外用剤全量中0.0001〜
10重量%が好ましく、特に0.01〜5重量%の範囲
が好ましい。0.0001重量%未満である場合、アル
ギナーゼ活性を増大させて保湿成分を産生せしめる効果
が十分に達成できないことがあり、また、10重量%を
越えて配合しても効果の増大は期待できない。In the present invention, the amount of the extract of the Kimitsu extract in the total amount of the external preparation for skin is 0.0001 to 0.0001 as a dry solid.
It is preferably 10% by weight, particularly preferably in the range of 0.01 to 5% by weight. If the amount is less than 0.0001% by weight, the effect of increasing the arginase activity to produce a moisturizing component may not be sufficiently achieved, and if the amount exceeds 10% by weight, the effect cannot be expected to be increased.
【0007】本発明の皮膚外用剤は化粧料、医薬品、医
薬部外品など外皮に適用される物を指し、従ってその剤
形も水溶液系、可溶化系、乳化系、粉末系、油液系、ゲ
ル系、軟膏系、水−油二層系、水−油−粉末三層系など
幅広い形態を取り得る。本発明の皮膚外用剤は、木通抽
出エキスの他に通常化粧品や医薬品などの皮膚外用剤に
用いられる水性成分、粉末、界面活性剤、油剤、保湿
剤、アルコール類、pH調節剤、防腐剤、酸化防止剤、増
粘剤、色素、香料などを必要に応じて適宜配合すること
により調製されることができる。[0007] The external preparation for skin of the present invention refers to those applied to the outer skin such as cosmetics, pharmaceuticals, and quasi-drugs. Therefore, the dosage form is also aqueous, solubilizing, emulsifying, powder, oil-liquid. , Gel, ointment, water-oil two-layer system, water-oil-powder three-layer system. The external preparation for skin of the present invention includes aqueous components, powders, surfactants, oils, humectants, alcohols, pH regulators, preservatives, which are commonly used in external preparations for skin such as cosmetics and pharmaceuticals, in addition to the extract of wood through the skin. , An antioxidant, a thickener, a dye, a fragrance, and the like, if necessary.
【0008】また、本発明の皮膚外用剤は、必要により
更に公知の薬剤を添加しても良い。これらの薬剤として
は、例えば、アスコルビン酸誘導体、プラセンタエキ
ス、グルタチオンなどの美白効果を有する薬剤、グリセ
リン、ソルビトールなどの保湿効果を有する薬剤、グリ
チルレチン酸誘導体、インドメタシンなどの抗炎症剤、
アロエ、ヘチマ、ユリなどの抽出物、ビオチン、パント
テン酸などの賦活剤、ビタミンE誘導体、ニコチン酸誘
導体などの血行促進剤などが挙げられ、このような薬剤
を用いることにより当抽出物との相乗効果により皮膚に
潤いと艷を与えることができる。Further, the external preparation for skin of the present invention may further contain a known agent if necessary. As these drugs, for example, ascorbic acid derivatives, placenta extract, drugs having a whitening effect such as glutathione, glycerin, drugs having a moisturizing effect such as sorbitol, glycyrrhetinic acid derivatives, anti-inflammatory agents such as indomethacin,
Extracts such as aloe, luffa, and lily; activators such as biotin and pantothenic acid; and blood circulation promoters such as vitamin E derivatives and nicotinic acid derivatives, and the like. The effect can give the skin moist and shiny.
【0009】[0009]
【実施例】以下の実施例によって本発明を更に詳細に説
明するが、本発明は、これにより限定されてはならな
い。実施例1:アルギナーゼ活性促進剤 木通抽出エキス 木通を、株式会社金井藤吉商店(東京都千代田区鍛冶町
1−9−11)から入手した。乾燥後粉砕した30gの
木通に300mlの水を加え70℃で3時間加熱した。そ
の後、濾過により抽出液から不溶物を除去し、得られた
濾液を減圧乾固して木通抽出エキスを得た。The present invention will be described in more detail with reference to the following examples, which should not be construed as limiting the invention. Example 1: An arginase activity enhancer, a wood extract extract, a wood extract , was obtained from Kanai Tokichi Shoten Co., Ltd. (1-9-11 Kaji-cho, Chiyoda-ku, Tokyo). After drying, 300 ml of water was added to 30 g of the pulverized trees and heated at 70 ° C. for 3 hours. Thereafter, insolubles were removed from the extract by filtration, and the obtained filtrate was dried under reduced pressure to obtain an extract of Kinatsu extract.
【0010】アルギナーゼ活性促進剤としての評価 上記操作により得られた木通抽出エキスを用いてアルギ
ナーゼ活性促進作用の測定を行った。ヒト表皮細胞を直
径10cmの培養皿内に蒔き、培養皿内が細胞で完全に覆わ
れる程度まで培養を継続した。その後、木通抽出エキス
をその培地中濃度が(抽出エキス乾燥重量として)0〜
0.01重量%となるように添加し、そして4日間培養
した。培養後、その培地と細胞を回収し、培地中のアル
ギナーゼの反応により生じた尿素量と、細胞中のアルギ
ナーゼ活性量を、測定した。各濃度ポイントはすべて5
点ずつ行った。培地中の尿素量を、和光純薬工業株式会
社製の尿素窒素−テストワコーを取り扱い説明書に従っ
て使用することにより測定した。培地0.02mlと発色
試薬(発色原液Aと発色原液Bを5:1で混合したも
の)5.0mlを混和し沸騰水浴中で25分間加熱後、流
水中で冷却し分光光度計を用いて530nmの吸光度を測
定し、別に求めた尿素の検量線より培地中の尿素量を換
算した。 Evaluation as an Arginase Activity Promoter The arginase activity promoting action was measured using the extract of Kindori obtained by the above procedure. Human epidermal cells were seeded in a culture dish having a diameter of 10 cm, and the culture was continued until the inside of the culture dish was completely covered with the cells. After that, the concentration of the extract of Kodori in the culture medium was 0 to 0 (as dry weight of the extract).
It was added to 0.01% by weight and cultured for 4 days. After the culture, the medium and the cells were collected, and the amount of urea generated by the reaction of arginase in the medium and the amount of arginase activity in the cells were measured. Each concentration point is 5
We went point by point. The amount of urea in the medium was measured by using urea nitrogen-test Wako manufactured by Wako Pure Chemical Industries, Ltd. according to the instruction manual. Mix 0.02 ml of medium and 5.0 ml of a coloring reagent (a mixture of a coloring stock solution A and a coloring stock solution B at 5: 1), heat in a boiling water bath for 25 minutes, cool in running water and use a spectrophotometer. The absorbance at 530 nm was measured, and the amount of urea in the medium was calculated from a separately determined urea calibration curve.
【0011】細胞中のアルギナーゼ活性量の測定を、細
胞を1mlの25mMトリス−塩酸緩衝液pH7.5中でホモ
ジナイズしたホモジネートを用いて測定した。ホモジネ
ート0.05ml、を1.5mlの栓付きのマイクロチュー
ブに移し取りアルギナーゼの活性化のため50℃で10
分間加熱処理を行った。0.04mlの0.1Mアルギニ
ン溶液を添加し37℃にて30分間インキュベートし
た。インキュベート終了後0.01mlの60%過塩素酸
を添加・混和し酵素反応を停止させ、そして10,00
0gで遠心分離を行い、そして得られた上清の尿素量
を、上述の培地中の尿素量と同様の方法にて測定した。
ここで、1時間当たり1マイクロモルの尿素を産生する
量をアルギナーゼ1ユニットとした。培地中の尿素量、
細胞内のアルギナーゼ活性量とも無添加の場合を100
として、5点の平均値を表1に示す。The amount of arginase activity in the cells was measured using a homogenate obtained by homogenizing the cells in 1 ml of 25 mM Tris-HCl buffer pH 7.5. Transfer 0.05 ml of the homogenate to a 1.5 ml stoppered microtube and incubate at 50 ° C. for activation of arginase at 10 ° C.
Heat treatment was performed for minutes. 0.04 ml of a 0.1 M arginine solution was added and incubated at 37 ° C. for 30 minutes. After the incubation was completed, 0.01 ml of 60% perchloric acid was added and mixed to stop the enzyme reaction.
Centrifugation was performed at 0 g, and the amount of urea in the obtained supernatant was measured in the same manner as the amount of urea in the medium described above.
Here, the amount that produced 1 micromol of urea per hour was defined as 1 unit of arginase. Urea content in the medium,
Arginase activity in cells is 100
Table 1 shows the average values of the five points.
【0012】 表 1 木通抽出エキスの 培地中尿素量 細胞内アルギナーゼ 培地中濃度(%) 活性量 0 100 100 0.0001 103 103 0.0005 150 253 0.001 281 352 0.01 303 384 0.05 354 486 Table 1 Amount of urea in the culture medium of the extract of Kinatsu Extraction concentration in the intracellular arginase medium (%) Active amount 0 100 100 0.0001 103 103 0.0005 150 253 0.001 281 352 0.01 303 384 0. 05 354 486
【0013】この結果より本発明に係るアルギナーゼ活
性促進剤が、アルギナーゼの活性促進作用効果に優れて
いることがわかる。The results show that the arginase activity promoter of the present invention is excellent in the arginase activity promoting effect.
【0014】実施例2:ヘアレスマウス塗布試験による
アルギナーゼ活性促進剤の効果 上述の通り、アルギナーゼ活性促進剤としての木通抽出
エキスは、培養細胞レベルにおいてアルギナーゼ活性を
促進し尿素の産生量を増大させることは明らかである
が、さらに動物を使用した試験においても同様の作用効
果を示すかどうかを調べるために、次のような試験を行
った。 Example 2: By hairless mouse application test
Effect of Arginase Activity Promoter As described above, it is clear that the extract of Mokutsu as an arginase activity promoter promotes arginase activity at the cultured cell level and increases the amount of urea produced. The following test was conducted to determine whether the same effect was exhibited in the test.
【0015】星野実験動物より購入した6週齢の雄性ヘ
アレスマウス(各群10匹)を用い0.01%の木通抽
出エキスを含む50%エタノール溶液200μlを塗布
し、その後この塗布を1日2回の頻度で30日間連続し
て行った。塗布期間終了後、SKICON−200を用
いて皮表角質層水分含量を測定した後、マウス皮膚を採
取し0.24M塩化アンモニウムpH9.4中に0℃で3
0分間浸した後、ピンセットを用いて真皮より剥離し表
皮のみを採取した。採取した表皮を湿重量の19倍量の
生理緩衝食塩水でホモジナイズした後、遠心分離を行
い、その上清の尿素量とアルギナーゼ活性量を測定し
た。尿素量の測定を、上述の培地中の尿素量を測定する
方法で、アルギナーゼ活性量の測定を、上述の培養細胞
のアルギナーゼ活性量の測定と同様の方法で行った。抽
出エキスを含まない50%エタノールのみの塗布群(比
較例1)と擬似操作だけ群(比較例2)とを比較例とし
て用いた。擬似塗布群を100として、各群の皮表角質
層水分含量、表皮ホモジネート中の尿素量、及びアルギ
ナーゼ活性量を表2に示す。 表 2 実施例2 比較例1 比較例2 皮表角質層水分含量 148 105 100 表皮中の尿素量 175 103 100 表皮中のアルギナーゼ活性量 154 98 100Using a 6-week-old male hairless mouse (10 mice in each group) purchased from a Hoshino experimental animal, 200 μl of a 50% ethanol solution containing 0.01% extract of wood through was applied, and then this application was performed for 1 day. The test was performed twice consecutively for 30 days. After the application period was completed, the skin stratum corneum moisture content was measured using SKICON-200, and the mouse skin was collected and placed in 0.24 M ammonium chloride pH 9.4 at 0 ° C.
After soaking for 0 minutes, the dermis was peeled off using tweezers, and only the epidermis was collected. The collected epidermis was homogenized with 19 times the wet weight of physiological buffered saline, followed by centrifugation, and the urea content and arginase activity content of the supernatant were measured. The amount of urea was measured by the above-described method of measuring the amount of urea in the medium, and the amount of arginase activity was measured by the same method as the above-described method of measuring the amount of arginase activity of the cultured cells. A group to which only 50% ethanol containing no extract was applied (Comparative Example 1) and a group to which only the simulated operation was applied (Comparative Example 2) were used as Comparative Examples. Table 2 shows the water content of the epidermal stratum corneum, the amount of urea in the epidermal homogenate, and the amount of arginase activity in each group, with the simulated application group taken as 100. Table 2 Example 2 Comparative Example 1 Comparative Example 2 Skin Epidermis Stratum Corneum Water Content 148 105 100 Urea Content in Epidermis 175 103 100 Arginase Activity Content in Epidermis 154 98 100
【0016】表2の結果から明らかなように本発明のア
ルギナーゼ活性促進剤はヘアレスマウス表皮中のアルギ
ナーゼ活性を上昇させ、尿素量を増加させ、そして角質
層の水分含量を増大させることが明らかとなった。ま
た、本試験において本発明に係るアルギナーゼ活性促進
剤を塗布した部位に、副作用、例えば、炎症性の過敏反
応の発生、紅斑の発生は見られず、それ故、本発明に係
るアルギナーゼ活性促進剤が、副作用を呈さない範囲内
で有効にアルギナーゼ活性を促進し、尿素量の産生を増
大させ、そして角質層の水分含量を増大させることがで
きることを確認した。As is clear from the results in Table 2, it is clear that the arginase activity enhancer of the present invention increases arginase activity in hairless mouse epidermis, increases urea content, and increases water content of the stratum corneum. became. In the test, the site to which the arginase activity promoter according to the present invention was applied had no side effects, such as the occurrence of an inflammatory hypersensitivity reaction or erythema, and therefore, the arginase activity promoter according to the present invention was not observed. However, it was confirmed that arginase could effectively promote arginase activity, increase the production of urea, and increase the water content of the stratum corneum within a range not causing side effects.
【0017】以下の実施例3〜6において、本発明に係
る皮膚外用剤の配合の例を挙げる。 実施例3(軟膏剤) 成 分 重量部 A 木通抽出エキス 0.001 白色ワセリン 25 ステアリルアルコール 22 B プロピレングリコール 12 ラウリル硫酸ナトリウム 1.5 防腐剤・酸化防止剤 適 量 香 料 適 量 精製水 適 量 ────────────────────────────── 全 量 100 Aに属する成分を湯浴上で溶かし(油相)、そして別に
Bに属する成分を加熱溶解する(水相)。得られた油相
に水相を添加し、撹拌して乳化させ、そして冷却して軟
膏剤を得た。In the following Examples 3 to 6, the present invention is applied.
An example of the formulation of a skin external preparation is given below. Example 3 (ointment) Component Parts by weight A Kodori Extract Extract 0.001 White Vaseline 25 Stearyl Alcohol 22 B Propylene Glycol 12 Sodium Lauryl Sulfate 1.5 Preservative / Antioxidant Appropriate Amount Perfume Appropriate Purified Water Appropriate Amount ──────────成分 Dissolve the components belonging to the total amount of 100 A in a hot water bath (oil phase) and separately
The components belonging to B are dissolved by heating (aqueous phase). Oil phase obtained
Add the aqueous phase to the mixture, stir to emulsify and cool to soften
A plaster was obtained.
【0018】実施例4(乳液) 成 分 重量部 木通抽出エキス 1 トリステアリン酸ポリオキシエチレン ソルビタン 1 モノステアリン酸グリセリル 0.5 スクワラン 6 トリオクタン酸グリセリル 2 オクタン酸セチル 2 ステアリルアルコール 2 メトキシケイ皮酸オクチル 2 1,3−ブチレングリコール 5 グリセリン 3 ニコチン酸アミド 1 防腐剤・酸化防止剤 適 量 香 料 適 量 精製水 適 量 ────────────────────────────── 全 量 100 上記各成分を70℃におい均一に乳化させて、乳液とし
た。[0018] Example 4 (milky lotion) Component Parts by weight Akebia extract 1 tristearate polyoxyethylene sorbitan 1 glyceryl monostearate 0.5 Squalane 6 glyceryl trioctanoate 2 cetyl octanoate 2 Stearyl alcohol 2-methoxy cinnamic acid Octyl 2, 1,3-butylene glycol 5 Glycerin 3 Nicotinamide 1 Preservative / antioxidant Appropriate amount Perfume Appropriate amount Purified water Appropriate amount ─────────────────── ─────────── Total amount 100 The above components were uniformly emulsified at 70 ° C to obtain an emulsion.
【0019】実施例5(パック剤) 成 分 重量部 木通抽出エキス 0.4 ジプロピレングリコール 3 ポリエチレングリコール 3 1,3−ブチレングリコール 1 グリセリン 2 ピロリドン・カルボン酸ナトリウム 1 乳 酸 0.5 乳酸ナトリウム 0.5 ポリビニルアルコール 12 エタノール 3 POE(10)テトラデシルエーテル 0.3 防腐剤・酸化防止剤 適 量 香 料 適 量 精製水 適 量 ────────────────────────────── 全 量 100 上記各成分を均一に溶かしてパック剤を得た。[0019] Example 5 (pack agent) Component Parts by weight Akebia extract 0.4 Dipropylene glycol 3 Polyethylene glycol 3 1,3-butylene glycol 1 Sodium 1 lactate 0.5 sodium lactate Glycerin 2-pyrrolidone-carboxylic acid 0.5 Polyvinyl alcohol 12 Ethanol 3 POE (10) tetradecyl ether 0.3 Preservative / antioxidant qs perfume qs Purified water qs ────────────── Total amount 100 The above components were uniformly dissolved to obtain a pack.
【0020】実施例6(化粧水) 成 分 重量部 木通抽出エキス 0.5 グリセリン 4 1,3−ブチレングリコール 4 エタノール 7 POE(20)オレイルエーテル 0.5 防腐剤・酸化防止剤 適 量 香 料 適 量 精製水 適 量 ────────────────────────────── 全 量 100[0020] Example 6 (Lotion) Component Parts by weight Akebia extract 0.5 Glycerin 4 1,3-butylene glycol 4 Ethanol 7 POE (20) oleyl ether 0.5 Preservative-antioxidant q.s. incense Appropriate amount Purified water appropriate amount ────────────────────────────── Total amount 100
【0021】精製水に、グリセリン及び1,3−ブチレ
ングリコールを溶解して、水溶液を得た。一方、別にエ
タノール、木通抽出エキス及びPOE(20)オレイル
エーテルを混合した。この混合物を上記水溶液に添加
し、溶解し、そして濾過して化粧水を得た。Glycerin and 1,3-butylene glycol were dissolved in purified water to obtain an aqueous solution. Separately, ethanol, Kimitsu extract and POE (20) oleyl ether were mixed. This mixture was added to the above aqueous solution, dissolved, and filtered to obtain a lotion.
【0022】[0022]
【発明の効果】以上詳述したごとく、本発明は、新規、
かつ、有効なアルギナーゼ活性促進剤を提供することが
でき、そしてその皮膚外用剤の形態にあるものは、角質
層の水分含量を増大させる優れた皮膚保湿効果を有し、
肌荒れ皮膚の改善に有用であり、かつ、安全性の高いも
のである。As described in detail above, the present invention provides a novel,
And, it can provide an effective arginase activity promoter, and in the form of a skin external preparation, has an excellent skin moisturizing effect of increasing the water content of the stratum corneum,
It is useful for improving rough skin and is highly safe.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/48 A61K 7/48 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 7/48 A61K 7/48
Claims (2)
分として含有するアルギナーゼ活性促進剤。An arginase activity promoter comprising an extract of Mokutsu as an active ingredient.
載のアルギナーゼ活性促進剤。2. The arginase activity promoter according to claim 1, which is in the form of an external preparation for skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15527496A JP3823373B2 (en) | 1996-06-17 | 1996-06-17 | Arginase activity promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15527496A JP3823373B2 (en) | 1996-06-17 | 1996-06-17 | Arginase activity promoter |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH107581A true JPH107581A (en) | 1998-01-13 |
JP3823373B2 JP3823373B2 (en) | 2006-09-20 |
Family
ID=15602324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15527496A Expired - Lifetime JP3823373B2 (en) | 1996-06-17 | 1996-06-17 | Arginase activity promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3823373B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000273496A (en) * | 1999-03-26 | 2000-10-03 | Nof Corp | Cleansing agent composition |
JP2001253816A (en) * | 2000-03-13 | 2001-09-18 | Nof Corp | Skin cosmetic |
WO2002024156A3 (en) * | 2000-09-23 | 2002-07-18 | Henkel Kgaa | Topical skin-treatment agent containing arginase |
JP2002241293A (en) * | 2001-02-13 | 2002-08-28 | Ichimaru Pharcos Co Ltd | Maillard reaction inhibitor |
JP2011126914A (en) * | 2011-03-18 | 2011-06-30 | Nof Corp | Arginase activity accelerator and dermal external medicine containing the same |
JP2014025952A (en) * | 2013-11-05 | 2014-02-06 | Fancl Corp | Skin pigmentation marker and technique for using the same |
JP2015017048A (en) * | 2013-07-10 | 2015-01-29 | 日本メナード化粧品株式会社 | Prevention and improvement agent for wrinkle formation on skin, hyaluronan production promoter, collagen production promoter and mmp inhibitor |
-
1996
- 1996-06-17 JP JP15527496A patent/JP3823373B2/en not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000273496A (en) * | 1999-03-26 | 2000-10-03 | Nof Corp | Cleansing agent composition |
JP2001253816A (en) * | 2000-03-13 | 2001-09-18 | Nof Corp | Skin cosmetic |
JP4523109B2 (en) * | 2000-03-13 | 2010-08-11 | 日油株式会社 | Skin cosmetics |
WO2002024156A3 (en) * | 2000-09-23 | 2002-07-18 | Henkel Kgaa | Topical skin-treatment agent containing arginase |
JP2002241293A (en) * | 2001-02-13 | 2002-08-28 | Ichimaru Pharcos Co Ltd | Maillard reaction inhibitor |
JP2011126914A (en) * | 2011-03-18 | 2011-06-30 | Nof Corp | Arginase activity accelerator and dermal external medicine containing the same |
JP2015017048A (en) * | 2013-07-10 | 2015-01-29 | 日本メナード化粧品株式会社 | Prevention and improvement agent for wrinkle formation on skin, hyaluronan production promoter, collagen production promoter and mmp inhibitor |
JP2014025952A (en) * | 2013-11-05 | 2014-02-06 | Fancl Corp | Skin pigmentation marker and technique for using the same |
Also Published As
Publication number | Publication date |
---|---|
JP3823373B2 (en) | 2006-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6562355B1 (en) | Comixture of dextran sulfate/escin for treating skin redness/edema and/or sensitive skin | |
JP2020529420A (en) | New cosmetic use of Nepherium rappaceum extract | |
JPH0873342A (en) | Skin external preparation or bathing agent containing rubi fructus extract | |
JPH07223933A (en) | Beautifying agent and external preparation for skin | |
JP2001206835A (en) | Collagen synthesis promoter and collagen metabolism activator | |
JP2952636B2 (en) | Melanin production inhibitor, method for producing the same, and whitening cosmetic containing the same | |
JP2003267887A (en) | Skin care preparation inhibiting chemokine expression | |
EP2214634B1 (en) | External preparations for mosturizing the skin containing litsea polyantha | |
JP3501832B2 (en) | Testosterone 5α-reductase inhibitor containing rhubarb extract and its application | |
JP4583655B2 (en) | Anti-allergic skin external composition | |
JPH107581A (en) | Arginase activity promoter | |
JP2001342112A (en) | Skin care preparation | |
KR101841118B1 (en) | Composition for skin external application comprising extract of scenedesmus sp. | |
JPH069422A (en) | Promoter for biosynthesis of hyaluronic acid | |
JPH06336422A (en) | External agent for skin | |
JPH1029927A (en) | Antiaging agent | |
JPH06305932A (en) | Skin external agent | |
JP2018127407A (en) | Epidermis normalization agent as well as external preparations and cosmetics containing the same | |
JP3822959B2 (en) | Anti-aging skin external preparation | |
JP3083105B2 (en) | Cosmetics | |
JPH09124500A (en) | Therapeutic agent for atopic dermatitis | |
JP3792745B2 (en) | Tyrosinase inhibitor | |
JP2000119133A (en) | Skin lotion for bleaching | |
JPH11228438A (en) | Preparation for external use for skin | |
JP5937465B2 (en) | Collagen production promoter, fibroblast proliferation promoter, wrinkle improving agent and skin external preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20051013 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20051013 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060606 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060619 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090707 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100707 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100707 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110707 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120707 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120707 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130707 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |